Stocks
Dyadic International, Inc.DYAI
NASDAQHealthcareBiotechnology$0.40
Price as of · delayed, not real-time
A biotechnology company developing proprietary fungal-based protein production platforms for use in pharmaceuticals and industrial enzymes. Its C1 expression system is licensed to partners for manufacturing biologic drugs, and the company generates revenue through licensing fees and research collaborations. Investors track DYAI for its potential to disrupt traditional mammalian cell-based production with lower-cost microbial fermentation.
52W Range: $0.34-$1.60
Congressional Interest in Dyadic International, Inc. (DYAI)
No congressional trades have been disclosed for Dyadic International, Inc. (DYAI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading DYAI?
No congressional trades found for this stock.